United Services Automobile Association Intercept Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $1.03 Million - $1.42 Million	-17,589 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$77.77 - $120.68 $42,773 - $66,374	-550 Reduced 3.03%	17,589 $1.4 Million
Q1 2019 May 13, 2019	BUY	$91.83 - $120.68 $1.36 Million - $1.79 Million	14,800 Added 443.25%	18,139 $2.03 Million
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $200,340 - $286,052	3,339 New	3,339 $280,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.